Manuel Hora
Manuel Hora
Verified email at
Cited by
Cited by
Physical basis of amyloid fibril polymorphism
W Close, M Neumann, A Schmidt, M Hora, K Annamalai, M Schmidt, ...
Nature communications 9 (1), 699, 2018
MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors
M Hora, R Sarkar, V Morris, K Xue, E Prade, E Harding, J Buchner, B Reif
PloS one 12 (7), e0181799, 2017
A Stable Mutant Predisposes Antibody Domains to Amyloid Formation through Specific Non-Native Interactions
CN Nokwe, M Hora, M Zacharias, H Yagi, J Peschek, B Reif, Y Goto, ...
Journal of molecular biology 428 (6), 1315-1332, 2016
The antibody light-chain linker is important for domain stability and amyloid formation
CN Nokwe, M Hora, M Zacharias, H Yagi, C John, B Reif, Y Goto, ...
Journal of molecular biology 427 (22), 3572-3586, 2015
Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains
M Hora, M Carballo-Pacheco, B Weber, VK Morris, A Wittkopf, J Buchner, ...
Scientific Reports 7, 41515, 2017
A residue-specific shift in stability and amyloidogenicity of antibody variable domains
CN Nokwe, M Zacharias, H Yagi, M Hora, B Reif, Y Goto, J Buchner
Journal of Biological Chemistry 289 (39), 26829-26846, 2014
Solid-and solution-state nuclear magnetic resonance spectroscopic studies on antibody light chain amyloid formation and interactions with epigallocatechin gallate
M Hora, M Carballo Pacheco, B Weber, J Buchner, B Strodel, B Reif
Amyloid 24 (sup1), 10-10, 2017
Solid-and Solution-State Nuclear Magnetic Resonance Spectroscopic Analysis of Amyloidogenic Immunoglobulin Light Chains and their Interactions with Epigallocatechin Gallate
MC Hora
Technische Universität München, 2016
The system can't perform the operation now. Try again later.
Articles 1–8